Shares of Virax Biolabs Group Limited (NASDAQ:VRAX – Get Free Report) traded down 2.5% on Tuesday . The stock traded as low as $1.96 and last traded at $1.99. 208,009 shares were traded during trading, a decline of 91% from the average session volume of 2,295,129 shares. The stock had previously closed at $2.04.
Virax Biolabs Group Trading Down 2.5 %
The business’s fifty day simple moving average is $2.50 and its two-hundred day simple moving average is $1.81.
About Virax Biolabs Group
Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company provides rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid tests, and neutralizing antibody tests under the ViraxClear brand name.
See Also
- Five stocks we like better than Virax Biolabs Group
- Why Are These Companies Considered Blue Chips?
- Palantir Cracks $50, Is There Still Time to Get on Board?
- What is a Death Cross in Stocks?
- Insider Buying Signals Upside for These 3 Stocks
- How to invest in marijuana stocks in 7 steps
- These 2 Big Players Are Set to Compete With Elon Musk’s Starlink
Receive News & Ratings for Virax Biolabs Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Virax Biolabs Group and related companies with MarketBeat.com's FREE daily email newsletter.
